(1S,3R,6S)-Ethyl Octahydrocyclopenta[C] Pyrrole-1-Carboxylate Hcl

A method for accessing the otherwise difficult-to-isolate bicyclic secondary amine in free base form directly in reactor utilizes a slurry of (1S,3R,6S)-ethyl octahydrocyclopenta[c]pyrrole-1-carboxylate HCl in anhydrous dichloromethane with 2.05 molar equivalents of powdered potassium carbonate at 20–25°C under a nitrogen pad. The resulting solution is filtered through a 0.2 µm PTFE cartridge into a pre-cooled jacket vessel charged with a mixed anhydride generated from N-Boc-trans-4-hydroxy-L-proline and isobutyl chloroformate at −18°C. Acylation proceeds to ≥98% conversion within 90 min as monitored by inline ReactIR tracking of the carbonyl stretch at 1745 cm⁻¹. After aqueous work-up with 10% w/w citric acid and crystallization from isopropanol/water 85:15 v/v, the coupled intermediate is isolated in 91% yield with a diastereomeric ratio exceeding 99.5:0.5 as determined by SFC on a Chiralpak AD-3 column (CO₂/methanol 80:20, 2.5 mL/min, 40°C, DAD 210 nm) calibrated against the undesired epimer. This intermediate, after Boc-deprotection with 4 N HCl in dioxane and subsequent cyclization, furnishes the core macrocyclic scaffold of an orally bioavailable hepatitis C virus NS3/4A protease inhibitor currently under Phase II evaluation. Residual palladium from a downstream Sonogashira coupling is controlled below 10 ppm per Ph. Eur. method 2.4.20, and the final enantiomeric purity is verified against a racemic reference standard synthesized via a Ritter reaction pathway. The entire sequence is executed in a multi-purpose cGMP suite conforming to ICH Q7 sections 8.3 (critical process parameters) and 12.7 (process validation) using a 200 L glass-lined steel reactor equipped with a retreat-curve impeller. Genotoxic impurities arising from the esterification step—specifically ethyl methanesulfonate and isobutyl chloride—are scrubbed to levels compliant with ICH M7 thresholds for a 1.5 g maximum daily dose, verified by LC-MS/MS employing a QTrap 6500+ in MRM³ mode.

What Limits Diastereomeric Excess in Ugi Four-Component Reactions Using this Amino Ester Hydrochloride as the Amine Input?

In a Ugi-4CR incorporating cyclohexyl isocyanide, paraformaldehyde, and 3-nitrobenzoic acid, the hydrochloride salt is directly weighed into a 100 mL Schlenk flask and suspended in 2,2,2-trifluoroethanol at a concentration of 0.3 M. Addition of 1.1 equivalents of N-methylmorpholine liberates the amine in situ, after which the aldehyde is introduced at 0°C to preclude premature isocyanide polymerization. The mixture is stirred for 72 h at ambient temperature under argon shielding. Analysis by reversed-phase HPLC on a C18 column (gradient from 20% to 90% acetonitrile in 0.05% aqueous trifluoroacetic acid over 25 min) reveals two major diastereomers in a 78:22 ratio when the reaction is run without Lewis acid additives. The diastereomeric ratio is determined after isolation of the product by flash chromatography on spherical silica 15–40 µm with detection at 254 nm. Introducing 1.0 equivalent of anhydrous zinc chloride shifts the ratio to 91:9 but retards the rate, requiring 120 h to reach equivalent conversion. The resulting densely functionalized dipeptoid is elaborated into a conformationally constrained arginine mimetic that inhibits the protein-protein interaction between PD-1 and PD-L1 with an IC₅₀ of 28 nM in a homogeneous time-resolved fluorescence assay calibrated against a reference inhibitor. Process safety evaluation of the Ugi sequence mandates that the total thermal output, as measured by a Mettler Toledo RC1e reaction calorimeter, remains below −120 W/kg during the exothermic amine liberation, and that the free isocyanide headspace concentration is maintained below 50 ppm via continuous nitrogen sweep. Residual solvent limits in the final peptide-mimetic intermediate comply with ICH Q3C options for class 2 solvents: methanol ≤ 3000 ppm, acetonitrile ≤ 410 ppm. Batch records for kilogram-scale campaigns reference ISO 13485:2016 sections on traceability of starting materials and ISO 14644-1 Class 8 cleanroom gowning protocols.

Reductive Amination Profile in a Continuous-Flow Mesoreactor

When the hydrochloride is transformed into N-benzyl derivatives under flow conditions, a 0.5 M solution of (1S,3R,6S)-ethyl octahydrocyclopenta[c]pyrrole-1-carboxylate HCl and 1.8 equivalents of diisopropylethylamine in tetrahydrofuran is mixed in a T-junction with a 0.55 M THF stream of benzaldehyde bearing 3 mol% acetic acid catalysis. The combined stream subsequently meets a 0.6 M solution of sodium cyanoborohydride in THF delivered through a 1/16-inch PFA coil packed with static mixing elements. Residence time in a 10 mL PEEK coil at 55°C is calibrated to 35 min, after which the crude reaction mixture is quenched with 2 N aqueous ammonia and separated in a Zaiput membrane-based liquid-liquid separator. Steady-state operation yields a benzylated product stream with an ee of 99.2% measured by chiral GC employing a β-DEX 225 column (30 m × 0.25 mm, 0.25 µm film, helium 1.2 mL/min). The product is isolated by continuous distillation at 40 mbar jacket temperature 118°C, and the free amine is directly telescoped into a Buchwald-Hartwig coupling with 4-bromobenzonitrile using Pd₂(dba)₃ (0.8 mol%) and Xantphos (1.6 mol%) in toluene at 105°C. This sequence affords a key penultimate for a cathepsin K inhibitor intended for osteoporosis treatment. The mesoreactor train is purged with argon before start-up, and oxygen level is verified below 500 ppm by a trace oxygen analyzer (Teledyne 3110). In-process control of the reductive amination monitors cyanide carryover into the organic phase; colorimetric testing with pyridine-barbituric acid reagent conforms to USP <151>, ensuring total cyanide in the isolated product is below the 250 ppm alarm threshold.

When the Hydrochloride Serves as a Chiral Pool Starting Material for BINAP-Phos Analogue Construction

The ethyl ester moiety undergoes chemoselective reduction with 2.2 equivalents of lithium aluminum hydride in refluxing THF (66°C, 8 h) to give the primary alcohol without erosion of the cis-ring junction geometry. After quenching according to the Fieser protocol and azeotropic drying with toluene, the alcohol is converted to the corresponding mesylate with methanesulfonyl chloride (1.05 eq) and triethylamine (1.5 eq) at −5°C in dichloromethane. Displacement with potassium diphenylphosphide generated in situ from chlorodiphenylphosphine and potassium metal in refluxing dioxane furnishes a phosphine ligand precursor in 68% overall yield after recrystallization from degassed ethanol. This chiral phosphine, when complexed with [Rh(COD)₂]BF₄, catalyzes the asymmetric hydrogenation of methyl (Z)-2-acetamidocinnamate in methanol at 30 bar hydrogen pressure, delivering N-acetylphenylalanine methyl ester in 96% ee as measured by HPLC on a Crownpak CR(+) column (perchloric acid pH 1.5/acetonitrile 90:10, 0.4 mL/min). The ligand is stored under argon at −20°C as a 0.1 M solution in anhydrous, oxygen-free toluene to prevent phosphine oxide formation. Molar catalyst loading is optimized at 0.05 mol% Rh, achieving turnover frequency exceeding 4,500 h⁻¹ without observable metal leaching as confirmed by ICP-OES analysis of the post-reaction solution (Pd, Fe, Rh all below 1 ppm). Off-gas hydrogen is monitored with a thermal conductivity detector; the process interlocks shut down the Parr stirred autoclave if hydrogen concentration exceeds 4% v/v in the nitrogen purge. The homochiral building block is subsequently integrated into a synthetic route targeting a sphingosine-1-phosphate receptor modulator, with the final active pharmaceutical ingredient manufactured under 21 CFR 210 and 211 guidelines.

A second-generation route to a bromodomain and extra-terminal domain (BET) inhibitor uses the hydrochloride without carbamate protection. The salt is suspended in anhydrous acetonitrile and treated with 2.5 equivalents of potassium fluoride-Celite at 50°C for 30 min to generate the free amine, which is immediately acylated by dropwise addition of a solution of 5-chloro-2-nitrobenzoic acid pentafluorophenyl ester (1.0 eq) in DMF. After 2 h, HPLC monitoring indicates complete consumption of the activated ester; quenching with 0.5 M aqueous HCl and extraction with ethyl acetate affords a nitrobenzamide intermediate. Catalytic hydrogenation over 5% Pd/C (Johnson Matthey type 87L, 0.04 mol eq) in ethanol at 50 psig reduces the nitro group to an aniline, which is directly telescoped into a reductive alkylation with 4-cyanobenzaldehyde and sodium triacetoxyborohydride in 1,2-dichloroethane, providing a triamine scaffold with an overall yield of 44% over four chemical steps. The BET inhibitor portfolio demands a detailed nitrosamine risk assessment per ICH Q3A(R2) and Q3B(R2); a confirmatory LC-MS/MS method using an APCI source in positive ion mode screens for N-nitroso intermediates with a limit of detection of 0.03 ppm. Only vendor batches accompanied by a signed certificate of analysis demonstrating nitrite content below 0.1 ppm by ion chromatography (Dionex ICS-6000) are accepted into the warehouse.

Epoxy Curing Kinetics Modified by a Rigid N-Heterocycle

The hydrochloride is neutralized in a 30% w/w methanolic KOH solution and the free amine is extracted into methyl ethyl ketone and dried to ≤500 ppm water as determined by Karl Fischer coulometry (ASTM E203). It is then formulated at 8.2 phr into a diglycidyl ether of bisphenol F (DGEBF, epoxide equivalent weight 167 g/eq) along with dicyandiamide as latent hardener and 0.5 phr of 2-methylimidazole accelerator. Cure behavior is analyzed by differential scanning calorimetry (TA Instruments Q2000) at a ramp rate of 10°C/min: the onset temperature shifts from 142°C (control without amine) to 121°C with the bicyclic amine, and the peak exotherm narrows from 38°C to 24°C FWHM, indicating a more uniform cross-link topology. Glass transition temperature of the fully cured plaque, measured by modulated DSC per ISO 11357-2:2020, reaches 168°C, whereas the analog without the octahydrocyclopenta[c]pyrrole modifier stalls at 153°C. The resin is cast and cured in a 450-ton Engel injection molding machine with a barrel temperature profile ranging from 80°C to 130°C across four zones, and mold temperature maintained at 175°C. Dielectric analysis (DEA) embedded sensors detect the ion viscosity minimum at 14 min, aligning with the gel point, and the vitrification point is estimated from the permittivity derivative at 28 min. The mold must be treated with a semi-permanent release coating containing no silicone oil to avoid catalyst poisoning. The resulting glass-fiber reinforced composite (E-glass, 60% by weight) exhibits a flexural modulus of 24.7 GPa per ASTM D790-17 and interlaminar shear strength of 78 MPa per ASTM D2344-22. This material is qualified for primary structural components in urban air mobility passenger vehicles, requiring full compliance with the UL 94 V-0 flammability classification and 14 CFR 25.853(a) vertical burn test conducted on a 12.7 mm thick specimen.

In the synthesis of a ryanodine receptor modulator with an azaspirocyclic core, the hydrochloride is first desalted with a 10% w/w aqueous NaOH solution to an internal pH of 10.8, extracted into isopropyl acetate, and dried over magnesium sulfate to a water content below 0.08%. The free amine then undergoes a titanium-mediated aldol reaction with glyoxylic acid monohydrate and cyclohexanone in tetrahydrofuran at −40°C, catalyzed by titanium tetrachloride (0.5 eq) and pyridine (1.1 eq). The intermediate β-hydroxy acid is isolated via pH-swing extraction and subjected to a Mitsunobu lactonization with diisopropyl azodicarboxylate (1.5 eq) and triphenylphosphine (1.5 eq) to afford a tricyclic lactone. Global reduction with borane-dimethyl sulfide complex yields a triamine diol, which, after selective monotosylation with tosyl chloride (1.02 eq) in pyridine at 3°C, cyclizes to the azaspiro skeleton under basic conditions. Crystallization from ethyl acetate/heptane 1:4 gives the free base with a purity exceeding 99.7 area% as determined by UPC²-MS (Waters ACQUITY UPC² system with QDa detector, Torus 2-PIC column, 3.0 mL/min CO₂/methanol gradient). The final active pharmaceutical ingredient is a calcium-release-activated calcium-channel modulator requiring a maximum daily dose of 5 mg; hence, any single unknown impurity is controlled below the ICH Q3A identification threshold of 0.10%, and all mutagenic impurities are managed through the purge factor rationale described in ICH M7(R2) addendum. A dedicated crystallizer equipped with focused beam reflectance measurement (Mettler Toledo ParticleTrack G400) monitors the antisolvent addition rate to avoid uncontrolled nucleation; the target chord length distribution Dv50 is maintained between 80 µm and 120 µm to ensure consistent downstream milling performance in a cone mill with a 1.0 mm rasp screen.